Table 4.
Gene sets enriched in the high LOX expression phenotype.
| Name | ES | NES | NOM p-val | FDR q-val |
|---|---|---|---|---|
| KEGG_ECM_RECEPTOR_INTERACTION | 0.847 | 2.496 | 0.000 | 0.000 |
| KEGG_PATHWAYS_IN_CANCER | 0.629 | 2.375 | 0.000 | 0.000 |
| KEGG_HEDGEHOG_SIGNALING_PATHWAY | 0.714 | 2.368 | 0.000 | 0.000 |
| KEGG_TGF_BETA_SIGNALING_PATHWAY | 0.698 | 2.331 | 0.000 | 0.000 |
| KEGG_JAK_STAT_SIGNALING_PATHWAY | 0.617 | 2.299 | 0.000 | 0.000 |
| KEGG_MAPK_SIGNALING_PATHWAY | 0.588 | 2.291 | 0.000 | 0.000 |
| KEGG_WNT_SIGNALING_PATHWAY | 0.526 | 1.937 | 0.000 | 0.005 |
| KEGG_MTOR_SIGNALING_PATHWAY | 0.609 | 2.020 | 0.002 | 0.002 |
NES, normalized enrichment score; NOM, nominal; FDR, false discovery rate. Gene sets with NOM p < 0.05 and FDR q < 0.05 are considered as significant.